Novel sGC stimulator improves outcomes in patients with HFrEF
- PMID: 32286511
- DOI: 10.1038/s41569-020-0382-z
Novel sGC stimulator improves outcomes in patients with HFrEF
Comment on
-
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.N Engl J Med. 2020 May 14;382(20):1883-1893. doi: 10.1056/NEJMoa1915928. Epub 2020 Mar 28. N Engl J Med. 2020. PMID: 32222134 Clinical Trial.
-
Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial.Circulation. 2020 Aug 25;142(8):717-719. doi: 10.1161/CIRCULATIONAHA.120.047086. Epub 2020 Mar 28. Circulation. 2020. PMID: 32223438 Review. No abstract available.
References
Original articles
-
- Armstrong, P. W. et al. Vericiguat in patients with heart failure and reduced ejection fraction. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1915928 (2020) - DOI - PubMed
-
- Butler, J. et al. Comparing the benefit of novel therapies across clinical trials: insights from the VICTORIA trial. Circulation https://doi.org/10.1161/CIRCULATIONAHA.120.047086 (2020) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical